A therapeutic composition comprising: a methamphetamine precursor a gel-forming polymer an emulsifier with a lipid backbone a disintegrant and a surfactant wherein the ratio of emulsifier to gel-forming polymer on a weight basis is between about 10:1 and 1:10.